Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Saved in:
Bibliographic Details
Title: Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.
Authors: Hogan S; CPC Clinical Research Aurora CO USA.; Denver Health Denver CO USA.; Department of Medicine University of Colorado Aurora CO USA., Szarek M; CPC Clinical Research Aurora CO USA.; Downstate Health Sciences University School of Public Health Brooklyn NY USA., Debus ES; University Heart & Vascular Center Hamburg-Eppendorf Hamburg Germany., Nehler M; CPC Clinical Research Aurora CO USA.; Department of Surgery University of Colorado Aurora CO USA., Anand SS; Population Health Research Institute, McMaster University and Hamilton Health Sciences Hamilton Ontario Canada., Patel MR; Duke Clinical Research Institute, Duke University Durham NC USA., Pap AF; Bayer AG Wuppertal Germany., Deng H; Janssen Research & Development Raritan NJ USA., Hodge S; Bayer AG Wuppertal Germany., Haskell LP; Janssen Research & Development Raritan NJ USA., Muehlhofer E; Bayer AG Wuppertal Germany., Berkowitz SE; CPC Clinical Research Aurora CO USA.; Department of Medicine University of Colorado Aurora CO USA., Bauersachs RM; Cardioangiology Center Bethanien Frankfurt, and Center for Thrombosis and Hemostasis, University of Mainz Mainz Germany., Bonaca MP; CPC Clinical Research Aurora CO USA.; Department of Medicine University of Colorado Aurora CO USA.
Source: Journal of the American Heart Association [J Am Heart Assoc] 2025 Nov 04; Vol. 14 (21), pp. e039752. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first